Guide to clinical sites in DCTs
By Curebase
How Co-Creation with DCT Vendors, Sponsors, and Sites Makes Participation in Decentralized Clinical Trials Easier For Sites
In this guide, we reflect on the relationship between decentralized clinical trial vendors, sponsors, and virtual, traditional, and hybrid trial sites in the design phase of clinical studies. This comprehensive review illustrates how different site models can and should participate in clinical studies and how sponsors and DCT vendors can design studies to include site-friendly elements.
- The relationship that exists between sponsors, DCT vendors, and sites and how this relationship can be optimized for more mutually beneficial partnerships.
- The need for implementation of site support systems while participating in clinical trials and the ways in which DCT tools can make participation more frictionless for site staff.
- How site voices are missing in study feedback which can be used to better understand the burden sites face and to properly identify the proper site models needed for studies.
- Technologies and services DCT vendors can offer sponsors to better facilitate feedback cycles and support systems for sites participating in their trials.
